How it's started

Rosie's story.

How a machine-learning founder used AI to build a cancer treatment for his dog - and what we're doing now.

In 2024, my dog Rosie was diagnosed with mast cell cancer. We tried surgery, chemotherapy, immunotherapy. Nothing worked. The vets gave her months to live.

Paul and Rosie, Sydney, 2025
Paul and Rosie, Sydney. 2025.

I am not a biologist. I have spent 17 years in machine learning. So I did what I know how to do. I started researching, using AI to map the specific mutations driving her cancer, design a personalised mRNA vaccine targeting those mutations, and coordinate its manufacture with researchers at UNSW.

In December 2025, Rosie received her first injection after a 14-hour drive to Queensland.

Three months later, the tumours on her legs had significantly reduced, significantly extending the timeline she'd been given.

The science already exists. Genomic sequencing, protein modelling, mRNA synthesis - the tools are there. What I built for Rosie was not new science. It was new access.

I should not have been the only person who could do this. A background in machine learning and months of obsessive research should not be the price of admission. Every dog owner facing this diagnosis deserves the same options I had, without having to become a citizen scientist to get them.

Where we are right now

The first end-to-end personalised cancer treatment protocol for dogs.

Together with our partners at UNSW, the University of Queensland, and the Garvan Institute, we have built and validated it.

We are currently running a trial in Australia. Applications are open worldwide - every case matters, and Australia is where we start.

Apply now